Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GS-2121 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on GS-2121 (Aug 2024). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GS-2121 | GS2121|GS 2121 | Limited information is currently available on GS-2121 (Aug 2024). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06532565 | Phase I | GS-2121 GS-2121 + Zimberelimab | Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors | Recruiting | USA | CAN | 0 |